STADA Arzneimittel

Tweet this page
<
2024
>
Registration as it was on 20 Aug 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

10,000€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    STADA Arzneimittel

    EU Transparency Register

    008507452878-73 First registered on 15 Feb 2024

    Goals / Remit

    STADA Arzneimittel AG is headquartered in Bad Vilbel, Germany. The company focuses on a three-pillar strategy consisting of consumer healthcare products, generics and specialty pharma. Worldwide, STADA Arzneimittel AG sells its products in more than 100 countries. In financial year 2023, STADA achieved group revenues of EUR 3,735 million and reported earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 802 million. As of 31 December 2023, STADA employed 11,667 people worldwide.

    Main EU files targeted

    EU Pharma Legislation Review, including intellectual property provisions, trade, public health and access to medicines

    Address

    Head Office
    Stadastrasse 2-18
    Bad Vilbel 61118
    GERMANY
    EU Office
    Stadastrasse 2-18
    Bad Vilbel 61118
    GERMANY

    Website

  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Medicines for Europe and constituent national off-patent medicines associations (https://www.medicinesforeurope.com/)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    10,000€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    0€ - 10,000€

    Other financial info

    No EU-level intermedaries used

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    Supporting Medicines for Europe outreach on medicines access

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard